AI Science Tracker

Institute for Protein Design

1 discovery from 2023

Discoveries

LuxSit: de novo luciferases active in the laboratory

The group designed new luciferases and identified three active enzymes among the initial designs. The 117-residue LuxSit catalyzes blue light with the DTZ substrate; its function is verified in the laboratory, while therapeutic or industrial applications remain prospective.

Technology: Family-wide hallucination and deep learning

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Designed luciferases were tested in activity assays with synthetic luciferin substrates; the most active design had catalytic efficiency comparable to native luciferases and high substrate selectivity.
  • Still unknown: The abstract does not state how many designs were tested or how many were active, and states no explicit limitations; therapeutic or industrial applications remain untested.
  • AI role: Deep learning generated idealized scaffolds with binding pockets and matching sequences used to design artificial luciferases.

Evidence sources: https://www.ipd.uw.edu/2023/02/machine-learning-generates-custom-enzymes/ · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1038/s41586-023-05696-3&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: press release. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 470 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.